577 Engineered non-pathogenic synthetic biotic producing L-arginine synergize with PD-1-based cancer immunotherapy

• Ning Li,
• Fernando Canale,
• Camilla Basso,
• Anna Sokolovska,
• Michela Perotti,
• Michael James,
• Wenjie Jin,
• Jean-Philippe Theurillat,
• Daniel Leventhal,
• Kip West,
• Jose Lora,
• Federica Sallusto,
• Roger Geiger

Affiliations

Ning Li

2Synlogic Inc., Boston, MA, USA

Fernando Canale

1Institute for Research in Biomedicine, Bellinzona, Switzerland

Camilla Basso

1Institute for Research in Biomedicine, Bellinzona, Switzerland

Anna Sokolovska

2Synlogic Inc., Boston, MA, USA

Michela Perotti

1Institute for Research in Biomedicine, Bellinzona, Switzerland

Michael James

2Synlogic Inc., Boston, MA, USA

Wenjie Jin

1Institute for Research in Biomedicine, Bellinzona, Switzerland

Jean-Philippe Theurillat

3Institute for Oncology Reserach, Bellinzona, Switzerland

Daniel Leventhal

2Synlogic Inc., Boston, MA, USA

Kip West

2Synlogic Inc., Boston, MA, USA

Jose Lora

2Synlogic Inc., Boston, MA, USA

Federica Sallusto

1Institute for Research in Biomedicine, Bellinzona, Switzerland

Roger Geiger

1Institute for Research in Biomedicine, Bellinzona, Switzerland